Use of Colistin in Critically Ill Patients

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Pharmacology

Background:

• Colistin use has resurged in the last two decades for treating extensively drug-resistant Gram-negative organisms.
• Its application is common in intensive care units (ICUs) owing to a scarcity of alternative therapeutic options.
• Significant knowledge gaps exist regarding the optimal clinical use and efficacy of colistin in critically ill patients.

Purpose of the Study:

• To critically review the current clinical use and utility of colistin in critically ill patients.
• To identify and highlight the existing evidence, or lack thereof, supporting common colistin prescribing practices in ICUs.

Main Methods:

• Comprehensive literature review of studies on colistin use in critically ill patients.
• Critical appraisal of existing evidence supporting current clinical practices.
• Analysis of knowledge gaps and areas requiring further controlled research.

Main Results:

• Colistin is a vital treatment option for extensively drug-resistant Gram-negative infections in ICUs.
• There is a notable deficiency in controlled clinical trials guiding colistin's application in this vulnerable patient population.
• Current prescribing practices often lack robust evidence-based support.

Conclusions:

• Colistin remains crucial for managing multidrug-resistant Gram-negative infections in critically ill patients.
• Further high-quality, controlled studies are urgently needed to establish evidence-based guidelines for colistin use in ICUs.
• Addressing these evidence gaps is essential for optimizing patient outcomes and antimicrobial stewardship.